Acorah Software Products - Accounts Production 16.4.675 false true false true No description of principal activity 7 December 2023 31 December 2024 31 December 2024 15333433 Mr Johann Hoschtitzky iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15333433 2023-12-06 15333433 2024-12-31 15333433 2023-12-07 2024-12-31 15333433 frs-core:CurrentFinancialInstruments 2024-12-31 15333433 frs-bus:PrivateLimitedCompanyLtd 2023-12-07 2024-12-31 15333433 frs-bus:FilletedAccounts 2023-12-07 2024-12-31 15333433 frs-bus:Micro-entities 2023-12-07 2024-12-31 15333433 frs-bus:AuditExempt-NoAccountantsReport 2023-12-07 2024-12-31 15333433 frs-bus:Director1 2023-12-07 2024-12-31
Registered number: 15333433
Heart Treatments London Ltd
Unaudited Financial Statements
For the Period 7 December 2023 to 31 December 2024
Balance Sheet
Registered number: 15333433
31 December 2024
£
Current assets 61,554
Creditors: Amounts Falling Due Within One Year (17,423 )
NET CURRENT ASSETS 44,131
TOTAL ASSETS LESS CURRENT LIABILITIES 44,131
Accruals and deferred income (750 )
NET ASSETS 43,381
CAPITAL AND RESERVES 43,381

Notes

1. General Information
Heart Treatments London Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15333433 . The registered office is 71 Anselm Road, London, SW6 1LH.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Johann Hoschtitzky
Director
05/09/2025